Rockwell Medical Future Growth
Future criteria checks 1/6
Rockwell Medical is forecast to grow earnings and revenue by 119.9% and 9.8% per annum respectively while EPS is expected to grow by 122.6% per annum.
Key information
119.9%
Earnings growth rate
122.6%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 9.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 103 | 1 | N/A | N/A | 2 |
12/31/2024 | 92 | -4 | N/A | N/A | 2 |
3/31/2024 | 87 | -9 | N/A | N/A | N/A |
12/31/2023 | 84 | -9 | -10 | -9 | N/A |
9/30/2023 | 81 | -9 | -10 | -10 | N/A |
6/30/2023 | 76 | -12 | -8 | -7 | N/A |
3/31/2023 | 76 | -13 | -12 | -11 | N/A |
12/31/2022 | 73 | -19 | -17 | -17 | N/A |
9/30/2022 | 69 | -25 | -26 | -26 | N/A |
6/30/2022 | 66 | -29 | -32 | -32 | N/A |
3/31/2022 | 63 | -32 | -31 | -31 | N/A |
12/31/2021 | 62 | -33 | -34 | -34 | N/A |
9/30/2021 | 62 | -32 | -34 | -33 | N/A |
6/30/2021 | 61 | -32 | -32 | -31 | N/A |
3/31/2021 | 62 | -31 | -36 | -36 | N/A |
12/31/2020 | 62 | -31 | -31 | -30 | N/A |
9/30/2020 | 63 | -30 | -27 | -26 | N/A |
6/30/2020 | 63 | -30 | -28 | -28 | N/A |
3/31/2020 | 62 | -33 | -30 | -28 | N/A |
12/31/2019 | 61 | -34 | -29 | -27 | N/A |
9/30/2019 | 63 | -36 | -29 | -28 | N/A |
6/30/2019 | 64 | -33 | -28 | -26 | N/A |
3/31/2019 | 64 | -35 | -22 | -21 | N/A |
12/31/2018 | 63 | -32 | -21 | -20 | N/A |
9/30/2018 | 61 | -32 | -21 | -19 | N/A |
6/30/2018 | 59 | -32 | -20 | -19 | N/A |
3/31/2018 | 58 | -27 | -22 | -21 | N/A |
12/31/2017 | 57 | -26 | N/A | -21 | N/A |
9/30/2017 | 56 | -22 | N/A | -16 | N/A |
6/30/2017 | 54 | -21 | N/A | -18 | N/A |
3/31/2017 | 54 | -20 | N/A | -16 | N/A |
12/31/2016 | 53 | -20 | N/A | -12 | N/A |
9/30/2016 | 54 | -21 | N/A | -16 | N/A |
6/30/2016 | 56 | -18 | N/A | -13 | N/A |
3/31/2016 | 55 | -16 | N/A | -14 | N/A |
12/31/2015 | 55 | -14 | N/A | -13 | N/A |
9/30/2015 | 56 | -15 | N/A | 4 | N/A |
6/30/2015 | 55 | -17 | N/A | 8 | N/A |
3/31/2015 | 55 | -17 | N/A | 11 | N/A |
12/31/2014 | 54 | -21 | N/A | 4 | N/A |
9/30/2014 | 54 | -23 | N/A | -21 | N/A |
6/30/2014 | 53 | -33 | N/A | -31 | N/A |
3/31/2014 | 53 | -41 | N/A | -50 | N/A |
12/31/2013 | 52 | -49 | N/A | -51 | N/A |
9/30/2013 | 51 | -54 | N/A | -50 | N/A |
6/30/2013 | 51 | -59 | N/A | -49 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RWMA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RWMA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RWMA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RWMA's revenue (9.8% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: RWMA's revenue (9.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RWMA's Return on Equity is forecast to be high in 3 years time